Entries tagged with “biotechnology”
Articles
17 articles found for biotechnology:
- Can Catalysts Drive Chemical Industry Away From Fossil Feedstocks?
Increasing the contribution of renewable energy sources is one of the key themes in meeting the climate change goals set under Paris Agreement. Despite the push for renewable energy coming from regulators, the corporate sector and academia, the percentage of total global primary energy demand met by wind and solar energy is still under 2% (as per the 2016 IEA Report). In order to reduce the overall carbon footprint, it is important to not only address energy sources but also explore and use no/low carbon feedstock sources and technologies.
- How single-use technologies drive process optimization in biopharmaceutical manufacturing
Fixed stainless steel systems have been the desired choice for manufacturing high volumes of biopharma drugs for many decades due to their mass-production capability. Over the last two to three years, Single-use systems has increasingly found application in commercial manufacturing of biologics as they are low in CAPEX and more suitable for smaller and less-funded companies and even contract manufacturing organizations (CMOs). Single-use systems eliminate the cleaning process entirely, saving not only on cost associated with manual labor but also on the time required to validate the stainless steel equipment prior to re-use, thus making it more sustainable than stainless steel technology.
- 3D Printing of Human Organs — Future Perspective & IP Scenario
Thousands of patients are waiting for a lifesaving transplant today. Some of these are critical cases, and mortality in those patients is high due to a dearth of suitable donors.
3D-Printed organs may emerge as a life-saver for such patients.
- Gene Therapy – Promising Method to Cure Diseases
Gene therapy is ‘the use of genes as medicines’, which involves the transfer of a therapeutic gene into specific cells of an individual to repair an unhealthy gene.
- Commercialization of Nano-additives — Labs to Market
Through the application of nanotechnology, existing products such as fuel, cement, or food can be manipulated on an atomic, molecular, or supramolecular scale by means of nano-additives/nano-fillers so as to enhance their physical or chemical properties.
- Personalization of Treatment: Moving from Volume to Value
The new healthcare ecosystem is increasingly becoming “patient-centric”. With the “one-drug-for-all” approach rapidly being replaced by personalized treatment, pharmaceutical companies are scouting for technology enablers to realize this goal.
- Biofuel from Algae – Energy Security for the Future
Biofuel is any fuel that can be obtained from organic matter through the process of biological carbon fixation.
- Biofuels – Hot Attraction among Alternative Energy Patent Seekers
The biofuel sector has attracted a considerable amount of research, with more than 2,500 patents filed every year since the past five years.
- The US IPO Market is on an Upswing in 2017
While the number of IPOs in the US decreased from 275 in 2014 to 105 in 2016, the US IPO market has rebounded in 1H2017. The rebound can be attributed to a backdrop of stable economic indicators, strong job growth & improved corporate earnings, all of which should make for low market volatility in the coming quarters.
- 8 Things to Look for in a Good Research Partner
If you're in business, you're at war.
Odds are you’re also trying to run a lean business, which means you've not got enough manpower to chuck into the trenches.
When it comes to gathering critical information about the markets, the competitors, or even the feasibility of key business decisions; most firms operating out there have in-house research experts that are a jack of all trades, but masters of none. And this might work in few cases.
Sometimes though, and this definitely sneaks up on the weary that aren’t wary, you’ll need to spring a little extra for situations that call for specific expertise.
Your first big decision is whether you want to tackle this internally, or hire a Research Partner. - 9 Things to Research Before You Enter a New Market
One man’s ignorance is another man’s opportunity.
In a world where external forces are impacting business’ success like never before, conventional wisdom and experience can no longer guide future strategies. To gain a strategic advantage, companies must learn about the what, where, and why of the market environment they plan to enter.
They need a good Competitive Intelligence (CI) strategy.
- Why Technology Surveillance Tools Are Not Enough for Tech Watch
When technology evolves at a breakneck pace, it is necessary for dynamic organizations to track the innovations and technological developments affecting their area of business, and be aware of the opportunities — and threats — coming their way.
- Why Tech Watch Should Be a Part of Your Competitive Intelligence (CI) Strategy
“Opportunities are never lost; someone will take the ones you miss.”
― Andy Rooney
- Edible Vaccines – A Research Area Waiting to Explode
Ease of administration and patient compliant due to oral delivery
- Dubai – A Rising Star of Medical Tourism
A number of significant investments as well as several favorable factors have made Dubai a medical tourism hotspot in the GCC region.
- Pharma Deal-Making: In the Pink Of Health
Deal-making in the global pharmaceuticals sector is booming, with no signs of slowing down.
- Upbeat US IPO activity, not for Unicorns though
The spectacular line-up of IPOs at the start of 2019 implied it would be a blockbuster year for the primary market in the US. The decline in issuances over 2018 was offset by increase in the value of issuances during the year. Unicorns such as Uber, Lyft, Slack that had raised billions in multiple rounds of private equity/VC funding seemed set to shatter the traditional 'path to profitability'. However, closer to the end of 2019, the picture is rather different: the IPOs of these 'gig economy', 'millennial focused' companies could not escape the scrutiny of a wider investor base in secondary markets. This clearly indicates that public investors do not share the same faith expressed by private equity investors in mere user aggregation and future monetization.
Blogs
7 blog posts found for biotechnology:
- Advantages of Nanoparticles Over Conventional Dosage in Cancer Treatment
- Mechanism of Targeting Tumor Cells Using Nanoparticles
- Bioprinting — The Next Big Thing in Organ Transplants
Made-to-order organs could be just round the corner.
- Benefits of Bioprinting in Pharma — Faster Testing & Cheaper Drugs
Testing new drugs and therapies on 3D printed human organs in a lab could reduce the time and costs of getting a new drug to market.
- Will IP Intelligence Revolutionize Patent Search?
- 409A Valuations — Are You Pricing Your Options Too High?
Start-up CFOs are fast realizing how early stage 409A valuations completed by quick cookie cutter, ‘textbook’ approach often result in inflated option prices and disgruntled employees. Naturally, a 409A valuation has to be more than just compliant; it has to be fair for your employees.
- Wondering What UK Sector is Your Safest Bet in 2016?
With global equity markets still adjusting to 2015’s turbulence, sectors such as housing as well as travel and tourism look like they’ll weather the storm to come out on top in the long run.
Infographics
6 infographics found for biotechnology:
- Factors Driving Nanoparticle-based Cancer Drug Delivery Systems
Conventional options for Cancer treatment are plagued with several issues such as poor water solubility, lack of targeting capability, non-specific distribution, systemic toxicity, and low therapeutic index, to name a few.
- Types of Prevalent Nanoparticles
Nanotechnology is a rapidly evolving domain, presenting solutions to various issues associated with conventional drug therapeutics such as poor water solubility, lack of targeting capability, non-specific distribution, systemic toxicity and low therapeutic index.
- Commercially Available Nanoparticles for Cancer Treatment
Since their advent in the late 1960s, several nanoparticle-based drugs are being clinically used in innovative therapeutic approaches with notable success.
- Nanoparticle-based Products Under Clinical Trials
Since their advent in the late 1960s, several nanoparticle-based drugs are being clinically used in innovative therapeutic approaches with notable success.
- CRISPR/Cas9 – Market Players Snapshot
We're entering a new era in molecular biology.
- World Intellectual Property Day : Visionary Innovators | Infographic
World Intellectual Property Day is earmarked as a day to recognize and encourage innovation and creativity.
Special Reports
3 special reports found for biotechnology:
- Gene Therapy - Advanced Treatments for a New Era
Gene therapy involves inserting/deleting/correcting genetic material into human cells to fight or prevent diseases. It is a promising tool not only for cancer but for several other diseases, such as Parkinson's, HIV, severe combined immuno-deficiencies and hemophilia, to name a few.
- Nanoparticle Drug Delivery Systems For Cancer Treatment
Nanotechnology is a rapidly evolving domain solving various issues associated with conventional drug therapeutics, including poor water solubility
- Therapeutic Vaccines for Alzheimer’s — Are We Close Enough?
Alzheimer's Disease (AD), one of the most common causes of dementia, accounts for nearly 70% of documented cases of Dementia across the world.
The pharmaceutical industry is exploring all available options to develop a successful therapy, and the global market for Alzheimer’s treatment is expected to grow at a CAGR of 10.5%, from $4.9 billion in 2013 to $13.3 billion by 2023.
This report covers current research into therapeutic vaccines for Alzheimer’s Disease (AD), with topics that include market drivers, challenges associated with developing safe next-gen therapeutics, vaccines and therapies currently under development, as well as the technology and commercial ecosystem for AD therapy.